Seizure News and Research

Latest Seizure News and Research

Researchers develop new epileptic seizure-detection method

Researchers at Concordia University have pioneered a computer-based method to detect epileptic seizures as they occur - a new technique that may open a window on the brain's electrical activity.

24 Mar 2011

Trend rising for deaths of children in cars and trucks

Sadly, March 8th marked the first child vehicular tragedy of the year when a mother came out of work only to realize she left her 6 month year old in the car. This preventable, yet horrific accident occurs more often than one would think.

15 Mar 2011

Patients with epilepsy-linked memory loss worry more than their physicians

Patients with epilepsy worry more than their physicians do about the patients' potential memory loss accompanying their seizure disorder, according to a recent study.

9 Mar 2011

New study unmasks molecule that can protect against epileptic seizure

For years brain scientists have puzzled over the shadowy role played by the molecule putrescine, which always seems to be present in the brain following an epileptic seizure, but without a clear indication whether it was there to exacerbate brain damage that follows a seizure or protect the brain from it. A new Brown University study unmasks the molecule as squarely on the side of good: It seems to protect against seizures hours later.

6 Mar 2011

FDA accepts Lundbeck's clobazam NDA for review

Lundbeck Inc. today announced the U.S. Food and Drug Administration has accepted for review a New Drug Application for the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome in patients two years and older.

5 Mar 2011

Cyberonics third quarter net sales increase 15.3% to $47.1 million

Cyberonics, Inc., a global leader in epilepsy management, today announced results for the quarter ended January 28, 2011.

2 Mar 2011

Despite FDA action, Deston still believes Auralgan as a safe and effective drug product

Deston Therapeutics LLC announced today that it is currently exploring its options to respond to a recent seizure of its Auralgan Otic Solution by the Federal Government and that it still believes that Auralgan is a safe and effective drug product.

28 Feb 2011

Vaccine lawsuit rejected by Supreme Court

The U.S. Supreme Court ruled on Tuesday against the parents of Hannah Bruesewitz, 18, who suffered seizures and permanent brain damage after receiving a diptheria-tetanus-pertussis (DTP) vaccine in 1993. The Bruesewitz family had sued Wyeth who was then the parent company of the maker of the DTP vaccine that Hannah received as an infant.

27 Feb 2011

Genentech granted FDA hearing on Avastin for metastatic breast cancer

Genentech, a member of the Roche Group, today announced the U.S. Food and Drug Administration (FDA) has granted a hearing to allow the company the opportunity to present its views on why Avastin® (bevacizumab) should remain FDA-approved for metastatic breast cancer (mBC). The FDA has scheduled the hearing for June 28 to 29, 2011.

25 Feb 2011

Antiepileptic drugs could make HIV drugs less effective

A Michigan State University researcher is looking to uncover the risks of treating seizures in HIV-positive patients, providing much-needed data on possible interactions between antiepileptic drugs and antiretroviral medicines that potentially could make HIV drugs less effective or the disease itself drug resistant.

23 Feb 2011

CVS condemns Supreme Court's decision to preempt all vaccine design defect lawsuits

The Coalition for Vaccine Safety condemns the decision of the U.S. Supreme Court in Bruesewitz v. Wyeth to preempt all vaccine design defect lawsuits in state and federal civil court. Quoting Justice Sotomayor's dissent, the majority "imposes its own bare policy preference over the considered judgment of Congress."

23 Feb 2011

Forest Labs enters definitive merger agreement to acquire Clinical Data

Forest Laboratories, Inc. and Clinical Data, Inc. today announced that they have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics, for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones related to Viibryd.

22 Feb 2011

Healthcare disparities seen in epilepsy patients with low socioeconomic status

A newly published report reveals patients with epilepsy and low socioeconomic status (SES) are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life. The study also indicates that low SES patients used the hospital emergency room more often and had more visits to a general practitioner than epileptic patients at higher socioeconomic levels. Full findings are now available in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

22 Feb 2011

Epilepsy patients with low SES more likely to have poor quality of life

A newly published report reveals patients with epilepsy and low socioeconomic status are more likely to have uncontrolled seizures, drug-related side effects, and a lower overall quality of life.

22 Feb 2011

New research: Fluid retention may explain drugs' risk of strokes and heart attacks

New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration if the cardiovascular effects of fluid retention had been better understood. Fluid retention may explain the increased risk of heart attacks and strokes of medications such as Vioxx, Bextra, and Avandia.

22 Feb 2011

Frequent, potentially avoidable readmissions are major driver of pediatric health care costs

Among a group of children's hospitals, nearly 20 percent of admissions and one-quarter of inpatient expenditures were accounted for by a small percentage of patients who have frequent recurrent admissions, according to a study in the February 16 issue of JAMA.

18 Feb 2011

Longer looks: KHN's best health policy picks from thought-provoking publications

A law under consideration in South Dakota would expand the definition of "justifiable homicide" to include killings that are intended to prevent harm to a fetus—a move that could make it legal to kill doctors who perform abortions.

18 Feb 2011

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2010.

17 Feb 2011

Harmful effects of energy drinks on children

A new study published in the journal Pediatrics on Monday examined the risks of consumption of high-caffeine energy drinks on children and young adults. The study notes that these drinks are linked to an array of serious events like heart palpitations, high blood pressure and even cardiac arrest and death. The risk rises if young adults consuming the drink suffer from chronic diseases or take other medications.

14 Feb 2011

Questcor's pricing issue

After Questcor Pharmaceuticals raised the price of the drug Acthar, its sole product, more than 10-fold in 2007, its shares began a climb from pennies to $14 and change. Acthar

14 Feb 2011

Seizure News and Research

Latest Seizure News and Research

Researchers develop new epileptic seizure-detection method

Trend rising for deaths of children in cars and trucks

Patients with epilepsy-linked memory loss worry more than their physicians

New study unmasks molecule that can protect against epileptic seizure

FDA accepts Lundbeck's clobazam NDA for review

Cyberonics third quarter net sales increase 15.3% to $47.1 million

Despite FDA action, Deston still believes Auralgan as a safe and effective drug product

Vaccine lawsuit rejected by Supreme Court

Genentech granted FDA hearing on Avastin for metastatic breast cancer

Antiepileptic drugs could make HIV drugs less effective

CVS condemns Supreme Court's decision to preempt all vaccine design defect lawsuits

Forest Labs enters definitive merger agreement to acquire Clinical Data

Healthcare disparities seen in epilepsy patients with low socioeconomic status

Epilepsy patients with low SES more likely to have poor quality of life

New research: Fluid retention may explain drugs' risk of strokes and heart attacks

Frequent, potentially avoidable readmissions are major driver of pediatric health care costs

Longer looks: KHN's best health policy picks from thought-provoking publications

Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010

Harmful effects of energy drinks on children

Questcor's pricing issue

Everything you need to know about epilepsy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Seizure News and Research

Latest Seizure News and Research

Everything you need to know about epilepsy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in